Back
Kiniksa Pharmaceuticals Vs. Gorman-Rupp Industry Stock Comparison
Buy
65
KNSA
Kiniksa Pharmaceuticals
Last Price:
19.76
Seasonality Move:
6.55%
Buy
66
GRC
Gorman-Rupp
Last Price:
32.55
Seasonality Move:
1.42%
Buy
65
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $19.77. The Score for KNSA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.60. The Score for GRC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $19.77
The current trend is moderately bullish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 57.46 | Buy |
| Chaikin Money Flow: | -201585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.54 - 20) | Buy |
| Bollinger Bands (100): | (18.01 - 20.25) | Buy |
GRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 37.3 | Sell |
| Chaikin Money Flow: | 54153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.28 - 35.6) | Sell |
| Bollinger Bands (100): | (33.38 - 37.66) | Sell |
KNSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.88 | Sell |
| 20-day SMA: | 19.18 | Buy |
| 50-day SMA: | 19.01 | Buy |
| 200-day SMA: | 17.93 | Buy |
| 8-day EMA: | 19.8 | Sell |
| 20-day EMA: | 19.37 | Buy |
| 50-day EMA: | 19.08 | Buy |
| 200-day EMA: | 17.84 | Buy |
GRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.94 | Sell |
| 20-day SMA: | 33.37 | Sell |
| 50-day SMA: | 35.99 | Sell |
| 200-day SMA: | 33.73 | Sell |
| 8-day EMA: | 32.86 | Sell |
| 20-day EMA: | 33.61 | Sell |
| 50-day EMA: | 34.87 | Sell |
| 200-day EMA: | 33.59 | Sell |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Kiniksa Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gorman-Rupp Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||